Ross Todd is the Editor/columnist for the Am Law Litigation Daily. He writes about litigation of all sorts. Previously, Ross was the Bureau Chief of The Recorder, ALM's California affiliate. Contact Ross at [email protected]. On Twitter: @Ross_Todd.
December 18, 2012 | The American Lawyer
Amgen to Pay $150 Million for Misdemeanor Charge of Misbranding Anemia DrugAmgen pled guilty to a misdemeanor count of misbranding its anemia drug, Aranesp, in U.S. district court on Tuesday, and agreed to pay a total of $150 million in criminal fines and forfeiture. According to the government, the biotechnology company promoted Aranesp for uses that were not approved by the FDA in order to take market share from Johnson & Johnson's anemia drug, Procrit.
By Ross Todd
3 minute read
September 06, 2013 | The American Lawyer
Another Judge Takes Aim at Robbins GellerTwo weeks after a Manhattan federal judge criticized Robbins Geller for bringing a securities complaint that "borders on the absurd," a federal judge in Brooklyn took a dig at the firm when she dismissed a lawsuit filed against Cablevision.
By Ross Todd
3 minute read
March 14, 2012 | The American Lawyer
Nixon Peabody Forms Alliance with China's Hylands Law FirmIn a bid to expand its reach in mainland China, Nixon Peabody announced Tuesday that it is teaming up with Beijing-based Hylands Law Firm, a fellow member of the TerraLex law firm network, reports The Am Law Daily.
By Ross Todd
2 minute read
July 30, 2013 | The American Lawyer
Covington, MoFo Guide JPMorgan to $410M FERC DealHappily for a brood of law firms with big bank clients, the Federal Energy Regulatory Commission is intent on beating up Wall Street for alleged market manipulation. The latest to strike a deal with FERC is JPMorgan Chase & Co., represented by a team from Covington & Burling and Morrison & Foerster.
By Ross Todd
3 minute read
November 23, 2011 | The American Lawyer
Simpson Thacher, Jones Day Take Lead on KKR's $7.2 Billion Samson BuyBy Ross Todd
2 minute read
June 15, 2012 | The American Lawyer
Kirkland and Willkie Ask MDL Panel to Transfer Facebook IPO Cases to New YorkFacebook's lawyers want all of the 40-plus cases filed over the company's initial public offering to be coordinated in Manhattan. The Second Circuit is considered to have better case law for securities defendants on loss causation than the Ninth Circuit, where Facebook is based, which could sharply limit damage claims. Plus, Nasdaq also faces stockholder claims in New York that it botched the IPO.
By Ross Todd
3 minute read
October 02, 2013 | The American Lawyer
MoFo Down But Not Out in N.Y. Cage Fight ChallengeNew York still hasn't beaten claims that the state's ban on mixed martial arts bouts is unconstitutional. But Ultimate Fighting Championship and its lawyers at Morrison & Foerster barely avoided a knockout in their lawsuit challenging the ban this week.
By Ross Todd
3 minute read
April 19, 2012 | Law.com
Apple and Sextet of Tech Firms Lose Dismissal Bid in Employee Antitrust Class ActionBy Ross Todd
1 minute read
August 02, 2012 | The American Lawyer
Wachtell Stomps Out Two-Year-Old Securities Class Action for MonsantoEverything's coming up (herbicide-resistant) roses for Monsanto this week at the Thomas F. Eagleton Federal Courthouse in St. Louis.
By Ross Todd
3 minute read
September 20, 2013 | The American Lawyer
Sanofi To Pay $40M to Settle Investor ClaimsThe company has agreed to settle a class action lawsuit brought by investors who accused it of misleading them about the likelihood it would win approval for a potential blockbuster drug to treat obesity.
By Ross Todd
2 minute read
Trending Stories